We’re excited to share a new preprint from 10x scientists showing how the #Xenium In Situ spatial platform quantified biomarkers in breast #cancer samples, providing a way to assess cancer risk. The study offers a robust approach to normalize and analyze gene expression across heterogeneous human tissue samples. Read the whole story here: https://lnkd.in/e6YPwP89
10x Genomics
Biotechnology Research
Pleasanton, California 269,200 followers
Powering researchers’ insights with innovative single cell, spatial biology, & in situ tools. 🧬🔬
About us
Cells are the basic unit of life. They power everything we do, and unlocking their secrets is the key to advancing our knowledge of every facet of biology, from development to disease. Our single cell, spatial, and in situ tools enable researchers to answer pressing questions about cells and their functional contributions to oncology, immunology, neuroscience, and much more—as evidenced by more than 5,500 publications citing our technology. We are dedicated to building the best products, delivering the best customer experience, and creating the best team to fuel new scientific discovery, no matter how challenging. And we won’t stop until all of the cells’ secrets are revealed.
- Website
-
http://10xgenomics.com
External link for 10x Genomics
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Pleasanton, California
- Type
- Public Company
- Founded
- 2012
Locations
-
Primary
Get directions
6230 Stoneridge Mall Rd
Pleasanton, California 94588, US
Employees at 10x Genomics
Updates
-
What if you could encode complex genetic perturbations into a single DNA sequence, easily integrate that sequence into the genome of a living cell, and watch its effects? What if you could see that biology in a high-throughput #singlecell #CRISPR screen? Now you can. A new technology, CRISPR-All, from researchers at Stanford University and the Arc Institute builds on the Universal 3’ workflow to enable this unprecedented capability, which can closely model natural cellular evolution, cancer transformation, and more. Learn more about this groundbreaking method here: https://lnkd.in/eKK9gAEK
-
-
10x Genomics reposted this
At our celebration of the Virtual Cell Challenge at NeurIPS over the weekend, fireside chat guest Andrej Karpathy shared that his first question when exploring AI for biology is: "Where do I get all of the bits?" For building virtual cell models, quantity, quality, and diversity of data all matter. At Arc we have been working hard to build the full stack, from data to models to discovery. Huge thanks to our experimental teams in Arc's Technology Centers and Core Labs for generating the high-quality datasets that made this challenge possible and to our computational teams for creating a task and evaluation framework that engaged the wider scientific community. Special thanks to our sponsors 10x Genomics and Ultima Genomics for helping us create all that data, and NVIDIA for the compute power to process and analyze it.
-
-
The Arc Institute Virtual Cell Challenge winners are here! Congratulations to each winning team for building exceptional virtual cell models using data generated with 10x Genomics’ GEM-X Flex technology. This competition shows that sensitive inputs can create AI models that reshape how we predict human biology–transforming drug discovery and disease research. Ready to keep building the next generation of cellular models? https://lnkd.in/gVTi9RwS #VirtualCellChallenge #AI
-
-
An incurable #cancer meets a promising new treatment target in this Science Translational Medicine study. Researchers used Chromium #singlecell as part of a comprehensive approach to reveal answers for how multiple myeloma arises. This remarkable work ID’d biomarkers within B-cell subpopulations, revealed regulatory mechanisms, uncovered a novel target for CAR T-cell therapy…and kicked off a Phase I clinical trial. Congratulations to the team! https://lnkd.in/gU4BbsiR
-
A recent benchmarking study highlighted in Nature Communications championed Xenium for consistently delivering higher transcript counts per gene compared to other platforms, without sacrificing specificity—a result of its robust signal amplification and sensitive probe design. Xenium’s reliability and technical sensitivity make it a top choice for spatial transcriptomic studies with FFPE samples. Read more: https://lnkd.in/eEpMMR2v
-
That’s a wrap! We are honored to be part of the ASTRA consortium to build an APAC-region 2000+ pan-cancer atlas at spatial resolution. Thank you to the amazing attendees. We loved talking to you about our #Xenium In Situ platform, and we're excited to continue partnering with Garvan Institute of Medical Research and The University of Tokyo on this project and beyond!
-
-
Talking single cell and spatial biology with the nation’s leading neuroscientists at #SfN25? Mindblowing. Catch the highlights!
Back on the West Coast for the Society for Neuroscience 2025 Annual Meeting this week — in a surprisingly rainy San Diego! The photos below highlight just a few of the things happening at the conference, including: 1. Joshua Talboom presenting how neuroscientists are using 10x Genomics single-cell and spatial platforms — highlighting Flex and Multiome in Parkinson’s disease research and Xenium in Alzheimer’s disease research. 2. Strong engagement at the 10x booth, with Joe Tolar, PhD, Christine Kao, Tu Luu, John Hoang, Marco Serra, Shauna Clark, Egon Ranghini, PhD, and Joshua Talboom connecting with researchers. 3. Marco Serra sharing his Visium HD 3' poster with current and future neuroscientists. 4. Weston Stauffer walking attendees through his Xenium Protein poster.
-
-
“[combining single cell and spatial] will increase the amount of biological insights that we get and, potentially, discovery potential because we'll be able to find markers that are circulating in the immune system at the same time as we really look in situ at the tissue structure that's being affected in the disease.” — Sarah Carl, Scailyte Wondering how to combine single cell and spatial technologies in your experiment? Reach out to us at https://bit.ly/4rauTCy
-
How will the ASTRA consortium’s pan-#cancer spatial atlas shape the future of precision #oncology and drug discovery? By giving the research community unmatched #singlecell #spatialtranscriptomics insights into 2,000+ samples across 10 cancer types, all powered by the #Xenium platform. Read the press release now and see how the Garvan Institute of Medical Research, The University of Tokyo, and 10x Genomics are leading the way: https://lnkd.in/gYnujSKT
-